Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE WAS VALUED AT USD 734.91 MILLION IN 2021 AND IS EXPECTED TO REACH USD 1.4 BILLION BY 2027, GROWING AT A CAGR OF 12.34%.
Fractional Flow Reserve (FFR) Market Research Report Includes Market Size, Share, Trends, Growth drivers by following Segments:
- Technology: Invasive and Non-Invasive
- Applications: Single-Vessel, and Multi-Vessel
- End-Users: Hospitals & Specialty Cardiac Centers, Office-Based Labs, Diagnostic Imaging Centers, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Market Share & Forecast, 2020–2025
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL FRACTIONAL FLOW RESERVE MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2027) | USD 734.91 Million |
| Market Size (2021) | USD 1.4 Billion |
| CAGR (2021-2027) | 12.34% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Technology(Invasive and Non-Invasive ), Application(Single-Vessel, and Multi-Vessel ), End-User( Hospitals & Specialty Cardiac Centers, Office-Based Labs, Diagnostic Imaging Centers, and Others ), and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
MARKET ANALYSIS
The global fractional flow reserve market was valued at USD 734.9 million in 2021 and is expected to reach USD 1.4 billion by 2027, growing at a CAGR of 12% during the forecast period. The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing stent insertion, and the cost of the treatment. The benefits of FFR are high; however, its usage is limited in the market. It is commonly used to decide the need for revascularization. The usage of non-invasive fractional flow reserve systems is increasing due to innovative methods in healthcare systems. As a part of the standard procedure to diagnose coronary artery disease (CAD), multiple non-invasive tests are performed on the patients complaining of stable chest pain and low or intermediate probability of CAD. Chest pain remains the second most common reason for adult emergency visits in the United States.
The increasing target population globally drives the demand.
The increasing target population will be a significant driving factor for the usage of fractional flow reserve systems. Cardiovascular diseases cause one-third of deaths worldwide. Ischemic heart disease (IHD) is one of the prevalent conditions. The IHD incidence is expected to increase due to an increase in obesity, metabolic syndrome, diabetic conditions, and the aged population. In the past two decades, there has been a significant increase in the aging population. According to the United Nations, one in every eleven people will be over 65 years old by 2050, up from one in every eleven in 2019. In addition, reduced physical activity, rapid urbanization, and globalization activities in LMICs have led to an increase in cardiovascular diseases, including IHD. In countries like the United States, the cost of IHD is approaching 1%-1.5% of the gross domestic product (GDP); in the case of LMICs, it accounts for 10% of total per capita healthcare expenditure. This increasing target population globally will drive the global fractional flow reserve market growth.
Technological Advancements Driving Faster Adoption.
The fractional flow reserve market is experiencing high technological advancements with non-invasive fractional flow reserve methods. This trend is augmenting the demand and adoption of next-generation FFR products among healthcare providers and end-users. The vendors such as Boston Scientific, Philips, and ACIST Medical Systems have launched next-generation products in the market. Artificial intelligence (AI) and machine learning also played an essential role in giving real patient experiences with FFR products. Compared with conventional methods, AI technology has helped the end-users analyze a large volume of cases in a shorter duration and provide equal quality treatment to all the patients irrespective of the number of patients diagnosed simultaneously. The end-users adopt image-based techniques such as FFR-CT and FFRangio more frequently due to the non-invasive assessment of coronary lesions.
SEGMENT ANALYSIS
Technology
The invasive fractional flow reserve systems are widely accepted as a standard technique for assessing lesion-specific ischemic in patients with 50% to 90% stenosis. The advancement in the invasive segment is limited. For instance, in 2020, Philips launched the first solid core pressure guidewire for the coronary interventional procedure.
The number of people admitted to the CATH labs is decreasing in developed countries due to the change in better diagnostics of coronary artery disease. The non-invasive method is revolutionizing the cardiac diagnostic segment. The FFR-CT has helped reduce the number of patients referred for unnecessary catheterization. There are many scenarios in which the patient is recommended for stents and other procedures without good quality data, where invasive FFR is ineffective in diagnosing the patient's condition. The FFR-CT (non-invasive) has proven to be better than the invasive methods, seen as a gatekeeper for CATH Labs in the market.
One of the primary reasons for the slower adoption of non-invasive FFR systems is that many clinicians still believe that angiography provides better results and that will be enough to decide the treatment pathway for the patients. It also depends on the local practitioners to determine the diagnostic steps; still, many prefer CT scans, nuclear tests, and Invasive angiography.
Application
The technological advancements in the market have made clinicians diagnose patients with multivessel diseases, which is a complex scenario for the invasive methods in the market. Non-invasive methods provide the 3D structure of the heart with the FFR value and indicate the possible stenosis locations. This is a major revolutionary product to treat patients with multivessel diseases. There is a constant increase in people admitted to hospitals suffering from multivessel diseases, especially in developing and developed countries.
End-User
Hospitals & Specialty Cardiac Centers: Hospitals are the first point of contact for any patients, especially during the emergency conditions like chest pain. This increases the number of people preferring the hospitals to undergo treatments, and hospitals invest in the latest technologies to attract better customers in the region. Most elective surgeries and complex cardiac surgeries are performed in specialty cardiac centers.
Office-Based Labs: It is one of the new evolutions in laboratory spaces. The movement of people and doctors away from the hospitals to get better attention and safer and quickest treatments are driving the demand for new labs like office-based labs in the market.
Diagnostic Imaging Centers predominantly invest in advanced products to attract customers; they partner with many clinics and hospitals, indirectly providing the services. They are expected to grow at a faster CAGR during the forecast period.
Geography
Many developed countries like the US are shifting from the volume-based to value-based approach in the healthcare systems. This is making the developed countries prefer advanced products like FFR-CT. Some European countries prefer using value-based products to enhance their quality of treatments, which is not the case with developing countries like India, China, Brazil, Mexico, and Turkey. Still, the preference is majorly for volume-based treatments, which are economical and provide results to treat the patients.
North America: The United States dominated the global fractional flow reserve market globally. The faster adoption of value-based products in the healthcare system, better awareness among clinicians, and increasing adoption of FFR-CT have made the US a major fractional flow reserve market shareholder.
Europe: Europe healthcare is a mixture of values-based and volume-based healthcare providers. The adoption is faster among the value-based treatment providers. The adoption of advanced technologies is low in some of the developing economies in Europe. The increasing number of CATH Labs and office-based labs are mainly driving the usage of advanced products and boosting the non-invasive fractional flow reserve market.
APAC: The region's adoption of advanced products like FFR is limited. There is a constant increase in the number of cardiovascular disease patients in the area, and the number of people undergoing diagnostics is increasing. The demand for invasive methods is still high in the APAC region compared to non-invasive techniques. Due to its increased potential in the market, it is expected to grow at its highest during the forecast period.
Latin America: Latin American countries are also seen as famous destinations for various medical treatments. The adoption of advanced technologies is high in urban hospitals to attract tourists. Due to lack of reimbursement, the usage by local patients is limited, and they prefer undergoing more economic tests in the market. In addition, the lack of skilled lab technicians also limits the people to use conventional methods in the market.
Middle East & Africa: The middle east& Africa region is growing at a lower CAGR than other countries. As per the recently available data, there are more than 1.1 billion people in that region, but only 20 countries have CATH labs. The potential for FFR-based products is high in the market due to the increased target population. The fractional flow reserve market demand will increase with more economical products.
VENDOR ANALYSIS
Abbott, ACIST Medical Systems, Boston Scientific, CathWorks, General Electric Company, Koninklijke Philips, Opsens, and Siemens Healthineers are key players in the global fractional flow reserve market.
Vendors like HeartFlow are applying advanced methodologies to launch better products. Their technology uses the competitional fluid dynamics model, proper segmentation of coronaries, helping to find the value through the place of interest, and produces an interactive image with the FFR values for the doctors to make accurate decisions. In addition, one of the major benefits of this FFR-CT is that it avoids the invasive angiogram and provides better results comparatively. In addition, they are also using AI technology for better enhancement of the results and accuracy in diagnostics.
CathWorks FFRangio received US FDA approval in 2018. In 2021, CathWorks System will receive National Reimbursement Approval in Japan.
Frequently Asked Questions
What is the estimated value of the global fractional flow market?
What is the growth rate of the global fractional flow market?
Which region has the highest growth rate in the Fractional Flow Reserve Market?
Which region has the largest Fractional Flow Reserve Market share globally?
Who are the key players in the FFR market?
The global fractional flow reserve market was valued at USD 734.91 million in 2021 and is expected to reach USD 1.4 billion by 2027, growing at a CAGR of 12%.
The following factors are likely to contribute to the fractional flow reserve market growth-
- New Technology Directions in FFR
- Rising Patient Population in CVDs
- Increasing Number of CATH Labs
Base Year: 2021
Forecast Year: 2022-2027
The study considers a detailed scenario of the present market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Key Vendors
- Abbott
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- ACIST Medical Systems
- Boston Scientific
- CathWorks
- General Electric Company
- Koninklijke Philips
- Opsens
- Siemens Healthineers
Segmentation by Technology
- Invasive
- Non-Invasive
Segmentation by Applications
- Single-Vessel
- Multi-Vessel
Segmentation by End-Users
- Hospitals & Specialty Cardiac Centers
- Office-Based Labs
- Diagnostic Imaging Centers
- Others
Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- APAC
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL FRACTIONAL FLOW RESERVE (FFR) MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 IMPACT OF NEXT-GEN DEVICES AUGMENTING NON-INVASIVE FFR METHODS
EXHIBIT 4 ACIST RXI MINI SYSTEM FEATURES
EXHIBIT 5 IMPACT OF FFR-OCT IMPROVING OUTCOMES IN DIABETIC PATIENTS
EXHIBIT 6 GLOBAL INCREASE OF TARGET POPULATION
EXHIBIT 7 IMPACT OF AI & ML REVOLUTIONIZING FFR-CT
EXHIBIT 8 IMPACT OF NEW TECHNOLOGY DIRECTIONS IN FFR
EXHIBIT 9 IMPACT OF RISING PATIENT POPULATION OF CVDS
EXHIBIT 10 INDICATIONS FOR FFR MANAGEMENT
EXHIBIT 11 IMPACT OF INCREASING NUMBER OF CATH LABS
EXHIBIT 12 HOSPITALS WITH CATHETERIZATION LABORATORIES AND ON-SITE CARDIAC SURGERY PER MILLION PEOPLE
EXHIBIT 13 IMPACT OF HIGH COST OF FFR
EXHIBIT 14 IMPACT OF TECHNICAL LIMITATIONS OF FFR
EXHIBIT 15 IMPACT OF LOWER ADOPTION OF FFR & RISE OF SUBSTITUTES
EXHIBIT 16 GLOBAL FFR MARKET 2021–2027 ($ MILLION)
EXHIBIT 17 GLOBAL FFR MARKET BY GEOGRAPHY (% SHARE)
EXHIBIT 18 GLOBAL FFR MARKET BY TECHNOLOGY (% SHARE)
EXHIBIT 19 GLOBAL FFR MARKET BY APPLICATIONS (% SHARE)
EXHIBIT 20 GLOBAL FFR MARKET BY END-USERS (% SHARE)
EXHIBIT 21 FIVE FORCES ANALYSIS 2021
EXHIBIT 22 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 23 GLOBAL FFR BY TECHNOLOGY
EXHIBIT 24 GLOBAL FFR MARKET BY TECHNOLOGY: OVERVIEW
EXHIBIT 25 GLOBAL FFR MARKET BY TECHNOLOGY: INCREMENTAL GROWTH
EXHIBIT 26 GLOBAL FFR MARKET BY TECHNOLOGY: ABSOLUTE GROWTH
EXHIBIT 27 GROWTH ANALYSIS: GLOBAL FFR MARKET BY TECHNOLOGY
EXHIBIT 28 GLOBAL FFR MARKET BY NON-INVASIVE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL NON-INVASIVE FFR MARKET 2021–2027 ($ MILLION)
EXHIBIT 30 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 31 GLOBAL INVASIVE FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL INVASIVE FFR MARKET 2021–2027 ($ MILLION)
EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 34 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 35 GLOBAL FFR MARKET BY APPLICATIONS
EXHIBIT 36 GLOBAL FFR MARKET BY APPLICATION: OVERVIEW
EXHIBIT 37 GLOBAL FFR MARKET BY APPLICATIONS: INCREMENTAL GROWTH
EXHIBIT 38 GLOBAL FFR MARKET BY APPLICATIONS: ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL SINGLE-VESSEL FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL SINGLE-VESSEL FFR MARKET 2021–2027 ($ MILLION)
EXHIBIT 41 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 42 GLOBAL MULTI-VESSEL FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL MULTI-VESSEL FFR MARKET 2021–2027 ($ MILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 45 INCREMENTAL GROWTH BY END-USERS 2021 & 2027
EXHIBIT 46 GLOBAL FFR MARKET BY END-USER
EXHIBIT 47 GLOBAL FFR MARKET BY END-USER: OVERVIEW
EXHIBIT 48 GLOBAL FFR MARKET BY END-USERS: INCREMENTAL GROWTH
EXHIBIT 49 GLOBAL FFR MARKET BY END-USERS: ABSOLUTE GROWTH
EXHIBIT 50 GROWTH ANALYSIS: FFR MARKET BY END-USER
EXHIBIT 51 GLOBAL FFR MARKET BY HOSPITALS & SPECIALTY CARDIAC CENTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET 2021–2027 ($ MILLION)
EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 54 GLOBAL FFR MARKET BY OFFICE-BASED LABS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL OFFICE-BASED LABS IN FFR MARKET 2021–2027 ($ MILLION)
EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 57 GLOBAL FFR MARKET BY DIAGNOSTIC IMAGING CENTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL FFR MARKET BY DIAGNOSTIC IMAGING CENTERS 2021–2027 ($ MILLION)
EXHIBIT 59 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 60 GLOBAL FFR MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL FFR MARKET BY OTHER END-USERS 2021–2027 ($ MILLION)
EXHIBIT 62 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 64 GLOBAL FFR MARKET BY GEOGRAPHY
EXHIBIT 65 GLOBAL FFR MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 66 GLOBAL FFR MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 67 FFR MARKET IN NORTH AMERICA: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 68 NORTH AMERICA FFR MARKET: KEY COUNTRIES
EXHIBIT 69 FFR MARKET IN NORTH AMERICA 2021–2027 ($ MILLION)
EXHIBIT 70 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 71 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 72 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 73 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 74 FRACTIONAL FLOW RESERVE MARKET IN THE US 2021–2027 ($ MILLION)
EXHIBIT 75 FFR MARKET IN CANADA 2021–2027 ($ MILLION)
EXHIBIT 76 CANADIAN RISKY LIFESTYLE PRACTICES
EXHIBIT 77 FFR MARKET IN EUROPE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 78 HOSPITALS WITH 24/7 CATH LABS PER MILLION IN EUROPE
EXHIBIT 79 EUROPE FFR MARKET: KEY COUNTRIES
EXHIBIT 80 FFR MARKET IN EUROPE 2021–2027 ($ MILLION)
EXHIBIT 81 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 82 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 83 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 84 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 85 FFR MARKET IN GERMANY 2021–2027 ($ MILLION)
EXHIBIT 86 FFR MARKET IN FRANCE 2021–2027 ($ MILLION)
EXHIBIT 87 FFR MARKET IN UK 2021–2027 ($ MILLION)
EXHIBIT 88 FFR MARKET IN ITALY 2021–2027 ($ MILLION)
EXHIBIT 89 FFR MARKET IN SPAIN 2021–2027 ($ MILLION)
EXHIBIT 90 FFR MARKET IN APAC: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 91 FFR MARKET IN APAC: KEY COUNTRIES
EXHIBIT 92 FFR MARKET IN APAC 2021–2027 ($ MILLION)
EXHIBIT 93 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 95 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 96 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 97 FFR MARKET IN JAPAN 2021–2027 ($ MILLION)
EXHIBIT 98 FFR MARKET IN CHINA 2021–2027 ($ MILLION)
EXHIBIT 99 FFR MARKET IN INDIA 2021–2027 ($ MILLION)
EXHIBIT 100 FFR MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)
EXHIBIT 101 FFR MARKET IN AUSTRALIA 2021–2027 ($ MILLION)
EXHIBIT 102 FFR MARKET IN LATIN AMERICA: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 103 LATIN AMERICA FFR MARKET: KEY COUNTRIES
EXHIBIT 104 FFR MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)
EXHIBIT 105 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 106 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 107 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 109 FRACTIONAL FLOW RESERVE MARKET IN BRAZIL 2021–2027 ($ MILLION)
EXHIBIT 110 FFR MARKET IN MEXICO 2021–2027 ($ MILLION)
EXHIBIT 111 FFR MARKET IN ARGENTINA 2021–2027 ($ MILLION)
EXHIBIT 112 MIDDLE EAST & AFRICA FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 113 MIDDLE EAST & AFRICA FFR MARKET: KEY COUNTRIES
EXHIBIT 114 FFR MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)
EXHIBIT 115 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 116 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 117 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 118 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 119 FFR MARKET IN TURKEY 2021–2027 ($ MILLION)
EXHIBIT 120 FFR MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)
EXHIBIT 121 FFR MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)
EXHIBIT 122 PURE& DIVERSIFIED COMPANIES IN GLOBAL FFR MARKET
EXHIBIT 123 GLOBAL FFR MARKET: MARKET DOMINANCE ANALYSIS
EXHIBIT 124 VENDORS IN GLOBAL FFR MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 125 ABBOTT: TOTAL REVENUE 2019-2021 ($ MILLIONS)
EXHIBIT 126 ABBOTT: R&D EXPENDITURE 2019-2021 ($ MILLIONS)
EXHIBIT 127 ABBOTT: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
EXHIBIT 128 ABBOTT: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)
EXHIBIT 129 BOSTON SCIENTIFIC: TOTAL REVENUE 2019-2021 ($ MILLIONS)
EXHIBIT 130 BOSTON SCIENTIFIC: R&D EXPENDITURE 2019-2021 ($ MILLIONS)
EXHIBIT 131 BOSTON SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
EXHIBIT 132 BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)
EXHIBIT 133 GE HEALTHCARE: TOTAL REVENUE 2019-2021 ($ MILLIONS)
EXHIBIT 134 GE HEALTHCARE: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
EXHIBIT 135 GE HEALTHCARE: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)
EXHIBIT 136 KONINKLIJKE PHILIPS: TOTAL REVENUE 2019-2021 ($ MILLIONS)
EXHIBIT 137 KONINKLIJKE PHILIPS: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
EXHIBIT 138 OPSENS: TOTAL REVENUE 2019-2021 ($ MILLIONS)
EXHIBIT 139 OPSENS: R&D EXPENDITURE 2019-2021 ($ MILLIONS)
EXHIBIT 140 SIEMENS HEALTHINEERS: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 141 SIEMENS HEALTHINEERS: R&D SPENDING 2019–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 TREATMENT FOR CORONARY ARTERY DISEASE
TABLE 4 EXAMPLES OF NEXT-GENERATION FFR PRESSURE WIRE CHARACTERISTICS
TABLE 5 COMPARISON OF IMAGE-DERIVED FFR SYSTEM
TABLE 6 APPROXIMATE COSTING FOR STAGES IN FFR CT
TABLE 7 FFR PRESSURE GUIDEWIRE FAILURE AND ASSOCIATED ADVERSE EVENTS COMPARISON AMONG DIFFERENT GUIDEWIRES
TABLE 8 GLOBAL NON-INVASIVE FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 9 GLOBAL NON-INVASIVE FFR MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 10 COMPARISON OF INVASIVE FFR MONITORING METHODS WITH SPECIFICATIONS
TABLE 11 GLOBAL INVASIVE FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 12 GLOBAL INVASIVE FFR MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 13 GLOBAL SINGLE-VESSEL FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 14 SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 15 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 16 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 17 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 18 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 19 OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 20 OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 21 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 22 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 23 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 24 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 25 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 ($ MILLION)
TABLE 26 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 (%)
TABLE 27 FFR MARKET BY APPLICATIONS IN NORTH AMERICA 2021-2027 ($ MILLION)
TABLE 28 FFR MARKET BY APPLICATIONS IN NORTH AMERICA 2021-2027 (%)
TABLE 29 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 ($ MILLION)
TABLE 30 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 (%)
TABLE 31 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 ($ MILLION)
TABLE 32 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 (%)
TABLE 33 FFR MARKET BY APPLICATIONS IN EUROPE 2021-2027 ($ MILLION)
TABLE 34 FFR MARKET BY APPLICATIONS IN EUROPE 2021-2027 (%)
TABLE 35 FFR MARKET BY END-USER IN EUROPE 2021-2027 ($ MILLION)
TABLE 36 FFR MARKET BY END-USER IN EUROPE 2021-2027 (%)
TABLE 37 PREVALENCE OF CVD AND ITS SUBTYPE IN PATIENTS WITH TYPE 2 DIABETES IN ITALY (%)
TABLE 38 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 ($ MILLION)
TABLE 39 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 (%)
TABLE 40 FFR MARKET BY APPLICATIONS IN APAC 2021-2027 ($ MILLION)
TABLE 41 FFR MARKET BY APPLICATIONS IN APAC 2021-2027 (%)
TABLE 42 FFR MARKET BY END-USER IN APAC 2021-2027 ($ MILLION)
TABLE 43 FFR MARKET BY END-USER IN APAC 2021-2027 (%)
TABLE 44 KOREAN ADULTS WITH CARDIOVASCULAR RISK FACTORS
TABLE 45 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 ($ MILLION)
TABLE 46 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 (%)
TABLE 47 FFR MARKET BY APPLICATIONS IN LATIN AMERICA 2021-2027 ($ MILLION)
TABLE 48 FFR MARKET BY APPLICATIONS IN LATIN AMERICA 2021-2027 (%)
TABLE 49 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 ($ MILLION)
TABLE 50 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 (%)
TABLE 51 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
TABLE 52 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 (%)
TABLE 53 FFR MARKET BY APPLICATIONS IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
TABLE 54 FFR MARKET BY APPLICATIONS IN MIDDLE EAST & AFRICA 2021-2027 (%)
TABLE 55 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
TABLE 56 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 (%)
TABLE 57 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 58 ACIST MEDICAL SYSTEM: MAJOR PRODUCT OFFERINGS
TABLE 59 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 60 CATHWORKS: MAJOR PRODUCT OFFERINGS
TABLE 61 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 62 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 63 OPSENS: MAJOR PRODUCT OFFERINGS
TABLE 64 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
TABLE 65 GLOBAL FFR MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
TABLE 66 GLOBAL FFR MARKET BY TECHNOLOGY 2021-2027 (%)
TABLE 67 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 ($ MILLION)
TABLE 68 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 (%)
TABLE 69 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 ($ MILLION)
TABLE 70 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 (%)
TABLE 71 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 ($ MILLION)
TABLE 72 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 (%)
TABLE 73 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 ($ MILLION)
TABLE 74 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 (%)
TABLE 75 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
TABLE 76 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 (%)
TABLE 77 GLOBAL FFR MARKET BY APPLICATION 2021-2027 ($ MILLION)
TABLE 78 GLOBAL FFR MARKET BY APPLICATION 2021-2027 (%)
TABLE 79 FFR MARKET BY APPLICATION IN NORTH AMERICA 2021-2027 ($ MILLION)
TABLE 80 FFR MARKET BY APPLICATION IN NORTH AMERICA 2021-2027 (%)
TABLE 81 FFR MARKET BY APPLICATION IN EUROPE 2021-2027 ($ MILLION)
TABLE 82 FFR MARKET BY APPLICATION IN EUROPE 2021-2027 (%)
TABLE 83 FFR MARKET BY APPLICATION IN APAC 2021-2027 ($ MILLION)
TABLE 84 FFR MARKET BY APPLICATION IN APAC 2021-2027 (%)
TABLE 85 FFR MARKET BY APPLICATION IN LATIN AMERICA 2021-2027 ($ MILLION)
TABLE 86 FFR MARKET BY APPLICATION IN LATIN AMERICA 2021-2027 (%)
TABLE 87 FFR MARKET BY APPLICATION IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
TABLE 88 FFR MARKET BY APPLICATION IN MIDDLE EAST & AFRICA 2021-2027 (%)
TABLE 89 GLOBAL FFR MARKET BY END-USER 2021-2027 ($ MILLION)
TABLE 90 GLOBAL FFR MARKET BY END-USER 2021-2027 (%)
TABLE 91 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 ($ MILLION)
TABLE 92 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 (%)
TABLE 93 FFR MARKET BY END-USER IN EUROPE 2021-2027 ($ MILLION)
TABLE 94 FFR MARKET BY END-USER IN EUROPE 2021-2027 (%)
TABLE 95 FFR MARKET BY END-USER IN APAC 2021-2027 ($ MILLION)
TABLE 96 FFR MARKET BY END-USER IN APAC 2021-2027 (%)
TABLE 97 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 ($ MILLION)
TABLE 98 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 (%)
TABLE 99 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
TABLE 100 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 (%)
TABLE 101 GLOBAL FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 102 GLOBAL FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 103 INVASIVE IN FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 104 INVASIVE IN FFR MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 105 NON-INVASIVE IN FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 106 NON-INVASIVE IN FFR MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 107 GLOBAL SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 108 GLOBAL SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 109 GLOBAL MULTI-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 110 GLOBAL MULTI-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 111 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 112 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 113 GLOBAL OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 114 GLOBAL OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 115 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 116 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 117 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 118 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY TECHNOLOGY
4.3.2 MARKET BY APPLICATIONS
4.3.3 MARKET BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.1.1 CAD DIAGNOSIS
7.2 FFR: AN OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 NEXT-GEN DEVICES AUGMENTING NON-INVASIVE FFR METHODS
8.2 FFR-OCT IMPROVING OUTCOMES IN DIABETIC PATIENTS
8.3 AI & ML REVOLUTIONIZING FFR-CT
9 MARKET GROWTH ENABLERS
9.1 NEW TECHNOLOGY DIRECTIONS IN FFR
9.2 RISING PATIENT POPULATION OF CVDS
9.3 INCREASING NUMBER OF CATH LABS
10 MARKET RESTRAINTS
10.1 HIGH COST OF FFR
10.2 TECHNICAL LIMITATIONS OF FFR
10.3 LOWER ADOPTION OF FFR & RISE OF SUBSTITUTES
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 GEOGRAPHY INSIGHTS
11.2.2 TECHNOLOGY INSIGHTS
11.2.3 APPLICATIONS INSIGHTS
11.2.4 END-USER INSIGHTS
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 TECHNOLOGY
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 NON-INVASIVE
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 NON-INVASIVE FFR BY GEOGRAPHY
12.4 INVASIVE
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 INVASIVE FFR BY GEOGRAPHY
13 APPLICATIONS
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SINGLE-VESSEL
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 SINGLE-VESSEL FFR BY GEOGRAPHY
13.4 MULTI-VESSEL
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MULTI-VESSEL FFR BY GEOGRAPHY
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 HOSPITALS & SPECIALTY CARDIAC CENTERS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 HOSPITALS & SPECIALTY CARDIAC CENTERS SEGMENTATION BY GEOGRAPHY
14.4 OFFICE-BASED LABS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 OFFICE-BASED LABS FFR BY GEOGRAPHY
14.5 DIAGNOSTIC IMAGING CENTERS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 DIAGNOSTIC IMAGING CENTERS SEGMENTATION BY GEOGRAPHY
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 OTHERS SEGMENTATION BY GEOGRAPHY
15 GEOGRAPHY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.2.1 NORTH AMERICA BY TECHNOLOGY
16.2.2 NORTH AMERICA BY APPLICATIONS SEGMENTATION
16.2.3 NORTH AMERICA BY END-USERS
16.3 KEY COUNTRIES
16.3.1 US: MARKET SIZE & FORECAST
16.3.2 CANADA: MARKET SIZE & FORECAST
17 EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 EUROPE BY TECHNOLOGY SEGMENTATION
17.2.2 EUROPE BY APPLICATIONS SEGMENTATION
17.2.3 EUROPE BY END-USER
17.3 KEY COUNTRIES
17.3.1 GERMANY: MARKET SIZE & FORECAST
17.3.2 FRANCE: MARKET SIZE & FORECAST
17.3.3 UK: MARKET SIZE & FORECAST
17.3.4 ITALY: MARKET SIZE & FORECAST
17.3.5 SPAIN: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 APAC BY TECHNOLOGY SEGMENTATION
18.2.2 APAC BY APPLICATIONS SEGMENTATION
18.2.3 APAC BY END-USER SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 JAPAN: MARKET SIZE & FORECAST
18.3.2 CHINA: MARKET SIZE & FORECAST
18.3.3 INDIA: MARKET SIZE & FORECAST
18.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
18.3.5 AUSTRALIA: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 LATIN AMERICA BY TECHNOLOGY SEGMENTATION
19.2.2 LATIN AMERICA BY APPLICATION SEGMENTATION
19.2.3 LATIN AMERICA BY END-USER SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 BRAZIL: MARKET SIZE & FORECAST
19.3.2 MEXICO: MARKET SIZE & FORECAST
19.3.3 ARGENTINA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 MIDDLE EAST & AFRICA BY TECHNOLOGY SEGMENTATION
20.2.2 MIDDLE EAST & AFRICA BY APPLICATIONS SEGMENTATION
20.2.3 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 TURKEY: MARKET SIZE & FORECAST
20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
21.2.1 ABBOTT
21.2.2 ACIST MEDICAL SYSTEM
21.2.3 BOSTON SCIENTIFIC
21.2.4 CATHWORKS
21.2.5 GE HEALTHCARE
21.2.6 KONINKLIJKE PHILIPS
21.2.7 OPSENS
21.2.8 SIEMENS HEALTHINEERS
22 KEY COMPANY PROFILES
22.1 ABBOTT
22.1.1 BUSINESS OVERVIEW
22.1.2 PRODUCT OFFERINGS
22.1.3 KEY STRATEGIES
22.1.4 KEY STRENGTHS
22.1.5 KEY OPPORTUNITIES
22.2 ACIST MEDICAL SYSTEMS
22.2.1 BUSINESS OVERVIEW
22.2.2 PRODUCT OFFERINGS
22.2.3 KEY STRATEGIES
22.2.4 KEY STRENGTHS
22.2.5 KEY OPPORTUNITIES
22.3 BOSTON SCIENTIFIC
22.3.1 BUSINESS OVERVIEW
22.3.2 PRODUCT OFFERINGS
22.3.3 KEY STRATEGIES
22.3.4 KEY STRENGTHS
22.3.5 KEY OPPORTUNITIES
22.4 CATHWORKS
22.4.1 BUSINESS OVERVIEW
22.4.2 PRODUCT OFFERINGS
22.4.3 KEY STRATEGIES
22.4.4 KEY STRENGTHS
22.4.5 KEY OPPORTUNITIES
22.5 GE HEALTHCARE
22.5.1 BUSINESS OVERVIEW
22.5.2 PRODUCT OFFERINGS
22.5.3 KEY STRATEGIES
22.5.4 KEY STRENGTHS
22.5.5 KEY OPPORTUNITIES
22.6 KONINKLIJKE PHILIPS
22.6.1 BUSINESS OVERVIEW
22.6.2 PRODUCT OFFERINGS
22.6.3 KEY STRATEGIES
22.6.4 KEY STRENGTHS
22.6.5 KEY OPPORTUNITIES
22.7 OPSENS
22.7.1 BUSINESS OVERVIEW
22.7.2 PRODUCT OFFERINGS
22.7.3 KEY STRATEGIES
22.7.4 KEY STRENGTHS
22.7.5 KEY OPPORTUNITIES
22.8 SIEMENS HEALTHINEERS
22.8.1 BUSINESS OVERVIEW
22.8.2 PRODUCT OFFERINGS
22.8.3 KEY STRATEGIES
22.8.4 KEY STRENGTHS
22.8.5 KEY OPPORTUNITIES
23 REPORT SUMMARY
23.1 KEY TAKEAWAYS
23.2 STRATEGIC RECOMMENDATIONS
24 QUANTITATIVE SUMMARY
24.1 TECHNOLOGY
24.1.1 NORTH AMERICA BY TECHNOLOGY SEGMENTATION
24.1.2 EUROPE BY TECHNOLOGY SEGMENTATION
24.1.3 APAC BY TECHNOLOGY SEGMENTATION
24.1.4 LATIN AMERICA BY TECHNOLOGY SEGMENTATION
24.1.5 MIDDLE EAST & AFRICA BY TECHNOLOGY SEGMENTATION
24.2 APPLICATION
24.2.1 NORTH AMERICA BY APPLICATION SEGMENTATION
24.2.2 EUROPE BY APPLICATION SEGMENTATION
24.2.3 APAC BY APPLICATION SEGMENTATION
24.2.4 LATIN AMERICA BY APPLICATIONS SEGMENTATION
24.2.5 MIDDLE EAST & AFRICA BY APPLICATION SEGMENTATION
24.3 END-USER
24.3.1 NORTH AMERICA BY END-USER SEGMENTATION
24.3.2 EUROPE BY END-USER SEGMENTATION
24.3.3 APAC BY END-USER SEGMENTATION
24.3.4 LATIN AMERICA BY END-USER SEGMENTATION
24.3.5 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
24.4 GEOGRAPHY
24.4.1 INVASIVE SEGMENTATION BY GEOGRAPHY
24.4.2 NON-INVASIVE SEGMENTATION BY GEOGRAPHY
24.4.3 SINGLE-VESSEL SEGMENTATION BY GEOGRAPHY
24.4.4 MULTI-VESSEL SEGMENTATION BY GEOGRAPHY
24.4.5 HOSPITALS & SPECIALTY CARDIAC CENTERS SEGMENTATION BY GEOGRAPHY
24.4.6 OFFICE-BASED LABS SEGMENTATION BY GEOGRAPHY
24.4.7 DIAGNOSTIC IMAGING CENTERS SEGMENTATION BY GEOGRAPHY
24.4.8 OTHERS SEGMENTATION BY GEOGRAPHY
25 APPENDIX
25.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the estimated value of the global fractional flow market?
What is the growth rate of the global fractional flow market?
Which region has the highest growth rate in the Fractional Flow Reserve Market?
Which region has the largest Fractional Flow Reserve Market share globally?
Who are the key players in the FFR market?
other RELATED Reports
Cardiac Assist Devices Market - Global Outlook and Forecast 2020-2025
Published : March 2020
